Ketoprofen Combined with UVA Irradiation Exerts Higher Selectivity in the Mode of Action against Melanotic Melanoma Cells than against Normal Human Melanocytes
Open Access
- 4 November 2021
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 22 (21) , 11966
Abstract
Malignant melanoma is responsible for the majority of skin cancer-related deaths. The methods of cancer treatment include surgical removal, chemotherapy, immunotherapy, and targeted therapy. However, neither of these methods gives satisfactory results. Therefore, the development of new anticancer therapeutic strategies is very important and may extend the life span of people suffering from melanoma. The aim of this study was to examine the effect of ketoprofen (KTP) and UVA radiation (UVAR) therapy on cell proliferation, apoptosis, and cell cycle distribution in both melanotic melanoma cells (COLO829) and human melanocytes (HEMn-DP) in relation to its supportive effect in the treatment of melanoma. The therapy combining the use of pre-incubation with KTP and UVAR causes a significant increase in the anti-proliferative properties of ketoprofen towards melanoma cells and the co-exposure of melanotic melanoma cells induced apoptosis shown as the mitochondrial membrane breakdown, cell-cycle deregulation, and DNA fragmentation. Moreover, co-treatment led to GSH depletion showing its pro-apoptotic effect dependent on ROS overproduction. The treatment did not show a significant effect on normal cells—melanocytes—which indicates its high selectivity. The results suggest a possible benefit from the use of the ketoprofen and ultraviolet A irradiation as a new concept of melanotic melanoma therapy.Keywords
Funding Information
- Medical University of Silesia in Katowice (PCN-2-041/N/0/F; PCN-1-097/K/0/F and PCN-2-042/N/0/F)
This publication has 49 references indexed in Scilit:
- Cell Cycle Regulation by Checkpoints2014
- Emerging Regulatory Paradigms in Glutathione Metabolism2014
- Targeting cell cycle regulation in cancer therapyPharmacology & Therapeutics, 2013
- Chromatin Collapse during Caspase-dependent Apoptotic Cell Death Requires DNA Fragmentation Factor, 40-kDa Subunit-/Caspase-activated Deoxyribonuclease-mediated 3′-OH Single-strand DNA BreaksJournal of Biological Chemistry, 2013
- Regulation of DNA fragmentation: the role of caspases and phosphorylationThe FEBS Journal, 2010
- Identification of ROS Using Oxidized DCFDA and Flow-Cytometry2009
- Apoptosis and glutathione: beyond an antioxidantCell Death & Differentiation, 2009
- Cytometric assessment of DNA damage in relation to cell cycle phase and apoptosisCell Proliferation, 2005
- Chemotherapy-Associated Oxidative Stress: Impact on Chemotherapeutic EffectivenessIntegrative Cancer Therapies, 2004
- Hsp27 as a Negative Regulator of Cytochrome c ReleaseMolecular and Cellular Biology, 2002